Investors in Harmonic Inc. HLIT need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 20, 2024 $7.50 Call had some of the highest implied ...

Third Harmonic Bio, Inc. (THRD) closed the last trading session at $15, gaining 20.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...

Harmonic posted third-quarter results ahead of expectations, but the maker of internet infrastructure forecast a challenged 2025 as customers reconsider deployment plans and timing. Shares, which ...

Harmonic Inc. reports strong Q3 results but faces concerns, leading to a cautious outlook. Click for more on HLIT Stock and its most recent earnings release.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 3.26% of ...

Research analysts at Northland Capmk raised their FY2024 earnings per share (EPS) estimates for Harmonic in a report issued ...

Harmonic (NASDAQ:HLIT – Get Free Report) was downgraded by Raymond James from a “strong-buy” rating to an “outperform” rating ...

Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases, ...

The Harmonic Drive is a key part of countless robotic applications. Incredibly simple yet quite odd to watch, this gear system is extremely precise with an impressive torque-to-weight ratio, even if ...

Robot actuators must generate high torques, but at the same time be light and compact. The ideal application for the Harmonic ...

Third Harmonic Bio, Inc. ( (THRD) ) has released its Q3 earnings. Here is a breakdown of the information Third Harmonic Bio, Inc. presented to ...